Serum Gc-globulin in paracetamol intoxication;GC-GLOBULIN VED PARACETAMOLFORGIFTNING

Ugeskrift for Laeger

Volumn 158, Issue 46, 1996, Pages 6609-6612

  Schiødt, Frank Vinholt ^a   Bondesen, Stig ^a   Tygstrup, Niels ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PARACETAMOL; VITAMIN D BINDING PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INTOXICATION; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER NECROSIS; MALE; PROTEIN BLOOD LEVEL;

ACETAMINOPHEN; ADULT; ANALGESICS; FEMALE; GLOBULINS; HEPATIC ENCEPHALOPATHY; HUMANS; MALE; POISONING; PROGNOSIS; VITAMIN D-BINDING PROTEIN;

EID: 0029860657     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lee WM, Galbraith RM. The ekstracellular actin-scavenger system and actin toxicity. N Engl J Med 1992; 326: 1335-41.
2. Haddad JD, Harper KD, Guoth M, Pietra GG, Sanger JW. Angiopathic consequences of saturating the plasma scavenger system for actin. Proc Natl Acad Sci USA 1990; 87: 1381-5.
3. Cooke NE, Haddad JG. Vitamin D binding protein (Gc-globulin). Endocr Rev 1989; 10: 294-307.
4. Kwiatkowski DJ, Mehl R, Izumo S, Nadal-Ginard B, Yin HL. Muscle is the major source of plasma gelsolin. J Biol Chem 1988; 263: 8239-43.
5. Kawakami M, Blum CB, Ramakrishnan R, Dell RB, Goodman DS. Turnover of the plasma binding protein for vitamin D and its metabolites in normal human subjects. J Clin Endocrinol Metab 1981; 53: 1110-6.
6. Lee WM, Emerson DL, Werner PAM, Arnoud P, Goldschmidt-Clermont PJ, Galbraith RM. Decreased serum group-specific component protein levels and complexes with actin in fulminant hepatic necrosis. Hepatology 1985; 5: 271-5.
7. Goldschmidt-Clermont PJ, Lee WM, Galbraith RM. Proportion of circulating Gc (vitamin D-binding protein) in complexed form: relation to clinical outcome in fulminant hepatic necrosis. Gastroenterology 1988; 94: 1454-8.
8. Young WO, Goldschmidt-Clermont PJ, Emerson DL, Lee WM, Jollow DJ, Galbraith RM. Correlation between extent of liver damage in fulminant hepatic necrosis and complexing of circulating group-specific component (vitamin D-binding protein). J Lab Clin Med 1987; 110: 83-90.
9. Larsen FS, Ranck L, Hjortrup A, Kirkegaard P, Clemmesen JO, Hansen BA. Fulminant leversvigt før og efter at levertransplantation blev indført på Rigshospitalet. Ugeskr Læger 1995; 157: 885-8.
10. Clemmesen JO, Larsen FS, Ott P, Hansen BA. Paracetamolforgiftning på en hepatologisk afdeling. Ugeskr Læger 1995; 157: 877-80.
11. Hansen BA, Larsen FS, Ranek L. Fulminant leversvigt. Ugeskr Læger 1993; 155: 688-90.
12. Goldschmidt-Clermont PJ, Galbraith RM, Emerson DL, Werner PA, Nel AE, Lee WM. Accurate quantitation of native Gc protein in serum and estimation of endogenous Gc:G-actin complexes by rocket immunoelectrophoresis. Clin Chim Acta 1985; 148: 173-83.
13. Tygstrup N. Determination of hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest 1966; 56: 118 25.
14. Lee WM, Galbraith RM, Watt GH, Hughes RD, McIntire DD, Hoffman BJ et al. Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. Hepatology 1995; 21: 101-5.
15. Schiødt FV, Bondesen S, Petersen I, Dalhoff K, Ott P, Tygstrup N. Ad mission levels of serum Gc-globulin: predictive value in patients with fulminant hepatic failure. Hepatology 1996; 23: 713-8.
16. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439 45.